Syncope in children and adolescents

Herzschrittmachertherapie & Elektrophysiologie
Matthias J Müller, Thomas Paul

Abstract

Syncope is common in children and adolescents. Neurally mediated syncope including pallid and cyanotic breath holding spells, vagovasal syncope and neurocardiogenic syncope is based on a common pathomechanism and accounts for approximately 75% of cases. A potentially life-threatening cardiac cause of syncope may be present in up to 6%. Detailed history, physical examination and 12-lead electrocardiogram (ECG) allow discrimination between benign and serious syncope in the majority of pediatric patients. Tilt-testing can be useful when diagnosis is unclear. In neurally mediated syncope, education on awareness of prodromes, modification of life-style and reassurance of the family on benign character of the disease is sufficient for preventing further syncopal episodes in the majority of cases. In pediatric patients unresponsive to these measures midodrine is often effective. Fludrocortisone and cardiac pacing may be considered in selected patients. β‑Blockers are not beneficial in pediatric neurally mediated syncope. Cardiac causes need specific disease-targeted therapy.

References

Mar 11, 1991·Pacing and Clinical Electrophysiology : PACE·J C PerryA Garson
Mar 1, 1994·Journal of the American College of Cardiology·S BalajiP C Gillette
Aug 1, 1993·Journal of the American College of Cardiology·M J Strieper, R M Campbell
Sep 18, 1999·Archives of Disease in Childhood·C Wren
Mar 26, 2003·Archives of Disease in Childhood·K A McLeod
Aug 4, 2004·The Journal of Pediatrics·Martial M MassinPaul Gérard
Oct 14, 2004·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Wouter WielingRoy Freeman
Feb 15, 2005·Journal of the American College of Cardiology·Mubadda A Salim, Thomas G Di Sessa
Dec 2, 2006·The Journal of Pediatrics·Zhang QingyouTang Chaoshu
Sep 28, 2007·Pediatric Cardiology·Antonios P Vlahos, Theofilos M Kolettis
Aug 29, 2009·European Heart Journal·UNKNOWN Task Force for the Diagnosis and Management of SyncopeWouter Wieling
Feb 2, 2010·Journal of the American College of Cardiology·Sami ViskinArthur A M Wilde
Sep 3, 2013·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Silvia G PrioriUNKNOWN Asia Pacific Heart Rhythm Society
Oct 29, 2014·Pediatrics International : Official Journal of the Japan Pediatric Society·Yakup ErgulVolkan Tuzcu
Jun 28, 2015·Cardiology Clinics·Khalil Kanjwal, Hugh Calkins
Oct 17, 2017·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·L H P M FilippiniA A M Wilde

❮ Previous
Next ❯

Citations

Jan 14, 2021·Wiener medizinische Wochenschrift·Katharina LandwehrMartin Poryo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Current Treatment Options in Cardiovascular Medicine
W H FabianK G Lurie
Pediatric Neurology
Jeffrey B AndersonCameron Thomas
© 2022 Meta ULC. All rights reserved